New Enterprise Associates 15, L.p. - Net Worth and Insider Trading
New Enterprise Associates 15, L.p. Net Worth
The estimated net worth of New Enterprise Associates 15, L.p. is at least $971 Million dollars as of 2024-11-05. New Enterprise Associates 15, L.p. is the 10% Owner of Arcellx Inc and owns about 6,745,262 shares of Arcellx Inc (ACLX) stock worth over $549 Million. New Enterprise Associates 15, L.p. is the 10% Owner of IonQ Inc and owns about 26,306,693 shares of IonQ Inc (IONQ) stock worth over $401 Million. New Enterprise Associates 15, L.p. is also the 10% Owner of Inozyme Pharma Inc and owns about 2,437,689 shares of Inozyme Pharma Inc (INZY) stock worth over $11 Million. Besides these, New Enterprise Associates 15, L.p. also holds Reneo Pharmaceuticals Inc (RPHM) , Eargo Inc (EAR) . Details can be seen in New Enterprise Associates 15, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that New Enterprise Associates 15, L.p. has not made any transactions after 2022-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of New Enterprise Associates 15, L.p.
New Enterprise Associates 15, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, New Enterprise Associates 15, L.p. owns 20 companies in total, including Eargo Inc (EAR) , Inozyme Pharma Inc (INZY) , and Annexon Inc (ANNX) among others .
Insider Ownership Summary of New Enterprise Associates 15, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EAR | Eargo Inc | 2020-10-20 | 10 percent owner |
INZY | Inozyme Pharma Inc | 2020-07-28 | 10 percent owner |
ANNX | Annexon Inc | 2020-07-23 | 10 percent owner |
2020-07-09 | 10 percent owner | ||
2016-05-13 | 10 percent owner | ||
2019-06-07 | 10 percent owner | ||
2018-12-07 | 10 percent owner | ||
2018-03-09 | 10 percent owner | ||
2015-06-16 | 10 percent owner | ||
2016-12-19 | 10 percent owner | ||
2018-12-07 | 10 percent owner | ||
2021-04-13 | 10 percent owner | ||
2021-06-24 | 10 percent owner | ||
2020-12-09 | 10 percent owner | ||
2021-07-29 | director & 10 percent owner | ||
2022-06-21 | 10 percent owner | ||
2021-07-21 | 10 percent owner | ||
2022-05-31 | 10 percent owner | ||
2022-06-08 | 10 percent owner | ||
2021-07-21 | 10 percent owner |
New Enterprise Associates 15, L.p. Latest Holdings Summary
New Enterprise Associates 15, L.p. currently owns a total of 5 stocks. Among these stocks, New Enterprise Associates 15, L.p. owns 6,745,262 shares of Arcellx Inc (ACLX) as of June 21, 2022, with a value of $549 Million and a weighting of 56.56%. New Enterprise Associates 15, L.p. owns 26,306,693 shares of IonQ Inc (IONQ) as of May 31, 2022, with a value of $401 Million and a weighting of 41.34%. New Enterprise Associates 15, L.p. also owns 2,437,689 shares of Inozyme Pharma Inc (INZY) as of July 28, 2020, with a value of $11 Million and a weighting of 1.11%. The other 2 stocks Reneo Pharmaceuticals Inc (RPHM) , Eargo Inc (EAR) have a combined weighting of 0.98% among all his current holdings.
Latest Holdings of New Enterprise Associates 15, L.p.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ACLX | Arcellx Inc | 2022-06-21 | 6,745,262 | 81.43 | 549,266,685 |
IONQ | IonQ Inc | 2022-05-31 | 26,306,693 | 15.26 | 401,442,766 |
INZY | Inozyme Pharma Inc | 2020-07-28 | 2,437,689 | 4.43 | 10,786,774 |
RPHM | Reneo Pharmaceuticals Inc | 2021-04-13 | 478,549 | 18.20 | 8,709,592 |
EAR | Eargo Inc | 2020-10-20 | 326,001 | 2.57 | 837,823 |
Holding Weightings of New Enterprise Associates 15, L.p.
New Enterprise Associates 15, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, New Enterprise Associates 15, L.p. has made a total of 2 transactions in Arcellx Inc (ACLX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Arcellx Inc is the acquisition of 312,500 shares on June 21, 2022, which cost New Enterprise Associates 15, L.p. around $5 Million.
According to the SEC Form 4 filings, New Enterprise Associates 15, L.p. has made a total of 1 transactions in IonQ Inc (IONQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in IonQ Inc is the sale of 2,922,966 shares on May 31, 2022, which brought New Enterprise Associates 15, L.p. around $17 Million.
According to the SEC Form 4 filings, New Enterprise Associates 15, L.p. has made a total of 1 transactions in Inozyme Pharma Inc (INZY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Inozyme Pharma Inc is the acquisition of 250,000 shares on July 28, 2020, which cost New Enterprise Associates 15, L.p. around $4 Million.
More details on New Enterprise Associates 15, L.p.'s insider transactions can be found in the Insider Trading History of New Enterprise Associates 15, L.p. table.Insider Trading History of New Enterprise Associates 15, L.p.
- 1
New Enterprise Associates 15, L.p. Trading Performance
GuruFocus tracks the stock performance after each of New Enterprise Associates 15, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by New Enterprise Associates 15, L.p. is 6.7%. GuruFocus also compares New Enterprise Associates 15, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by New Enterprise Associates 15, L.p. within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how New Enterprise Associates 15, L.p.'s insider trading performs compared to the benchmark.
Performance of New Enterprise Associates 15, L.p.
New Enterprise Associates 15, L.p. Ownership Network
Ownership Network List of New Enterprise Associates 15, L.p.
Ownership Network Relation of New Enterprise Associates 15, L.p.
New Enterprise Associates 15, L.p. Owned Company Details
What does Eargo Inc do?
Who are the key executives at Eargo Inc?
New Enterprise Associates 15, L.p. is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .
Eargo Inc (EAR) Insider Trades Summary
Over the past 18 months, New Enterprise Associates 15, L.p. made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 1,528 shares made by William Brownie , a net sale of 38 shares made by Adam Laponis , and a net sale of 6 shares made by Mark Thorpe .
In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,630 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,630 shares.
Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eargo Inc Insider Transactions
New Enterprise Associates 15, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for New Enterprise Associates 15, L.p.. You might contact New Enterprise Associates 15, L.p. via mailing address: 1954 Greenspring Drive, Suite 600, Timonium Md 21093.